Results of CytoDyn’s PRO 140 CD01 Trial and Extension Study Published in HIV Clinical Trials
Data Provide Support for PRO 140 as long-acting, HIV-1 maintenance therapy VANCOUVER, Washington, May 24, 2018 (GLOBE NEWSWIRE) -- CytoDyn ...
Tag: CytoDyn Inc
© Copyright 2022 publicwire.com